ASOCIACION AELIP

Top of Page
Menu

Otras Publicaciones


1. Yiping Tu, Sofía Sánchez-Iglesias, David Araújo-Vilar, Loren G. Fong, and Stephen G. Young. LMNA missense mutations causing familial partial lipodystrophy do not lead to an accumulation of prelamin A. Nucleus, 2016  2;7(5):512-521. IF: 3,03

2.  RJ Brown, D Araujo-Vilar, PT Cheung, D Dunger, A Garg, M Jack, L Mungai, EA Oral, N Patni, K Rother, J von Schnurbein, E Sorkina, T Stanley, C Vigouroux, M Wabitsch, R Williams, T Yorifuji. The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline. J Clin Endocrinol Metab 20162016 Dec;101(12):4500-4511, IF: 6.310


3. Panikkath R, Panikkath D, Sanchez-Iglesias S, Araujo-Vilar D, Lado-Abeal J. An Uncommon Association of Familial Partial Lipodystrophy, Dilated Cardiomyopathy, and Conduction System Disease. J Investig Med High Impact Case Rep. 2016 Jul 15;4(3):2324709616658495.

4. Jéru I, Vatier C, Araujo-Vilar D, Vigouroux C, Lascols O. Clinical Utility Gene Card for: Familial Partial Lipodystrophy. Eur J Hum Genet. 2016 Aug 3. doi: 10.1038/ejhg.2016.102. IF: 4.349

5. Sofía Sánchez-Iglesias, Alexander Unruh-Pinheiro, Cristina Guillín-Amarelle, Blanca González- Méndez, Alejandro Ruiz-Riquelme, Leticia Rodríguez-Cañete, Silvia Rodríguez-García, Encarnación Guillén-Navarro, Rosario Domingo-Jiménez, David Araújo-Vilar (corresponding author). Skipped BSCL2 transcript in Celia’s Encephalopathy (PELD): in vitro studies on senescence, adipogenesis and fatty acid treatment. PLOS ONE 2016 Jul 8;11(7):e0158874. doi: 10.1371/journal.pone. 0158874, IF: 3.234

6. Jéru I, Vatier C, Araujo-Vilar D, Vigouroux C, Lascols O. Clinical Utility Gene Card for: Congenital Generalized Lipodystrophy. Eur J Hum Genet. 2016 May 18. doi: 10.1038/ejhg.2016.53. IF: 4.349

7. C Guillín-Amarelle, S Sánchez-Iglesias, A Castro-Pais, L Rodriguez-Cañete, L Ordóñez-Mayán, Marcos Pazos, B González-Méndez, S Rodríguez-García, F.F. Casanueva, A Fernández-Marmiesse, D Araújo-Vilar (corresponding author). Type 1 Familial Partial Lipodystrophy: Understanding the Köbberling Syndrome. Endocrine, 2016 DOI: 10.1007/s12020-016-1002-x., IF: 3.878

8.  David Araújo-Vilar, Jesús Barreiro, Sofía Sánchez-Iglesias, Cristina Guillín-Amarelle. Acantosis nigricans en los síndromes de resistencia grave a la insulina. An. Pediatr (Barc.). 2016 Feb 15. pii: S1695-4033(16)00011-4. doi: 10.1016/j.anpedi.2016.01.003 IF:0.35

9.  Alejandro Ruiz-Riquelme, Sofía Sánchez-Iglesias, Alberto Rábano, Encarna Guillén-Navarro, Rosario Domingo-Jiménez, Adriana Ramos, Isaac Rosa, Peter Nilsson, Ángel García, David Araújo-Vilar (corresponding author) and Jesús R. Requena. Larger aggregates of mutant seipin are part of the molecular basis of Celia’s Encephalopathy, a fatal neurodegenerative syndrome associated to the BSCL2 gene. Neurobiology of Diseases, 2015 Aug 15;83:44-53. doi: 10.1016/ j.nbd.2015.08.006. IF: 5.2

10. Araujo-Vilar D, Sánchez-Iglesias S, Guillín-Amarelle C, Castro A, Lage M, Pazos M, Rial JM, Blasco J, Guillén-Navarro E, Domingo-Jiménez R, Del Campo MR, González-Méndez B, Casanueva FF. Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience. Endocrine; 49(1):139-47, 2015 IF: 3.527

11. Aráujo-Vilar D, Guillín-Amarelle C, Sánchez-Iglesias S, Castro A, Casanueva FF. Therapeutical uses of recombinant human leptin. Endocrinol Pediat, 2014,5 (Suppl): 27-42.

12. Guillín-Amarelle C, Sánchez-Iglesias S, Araujo-Vilar D (corresponding author). Uncommon lipodystrophic syndromes. Medicina Clínica (Barc). 20;144(2):80-7, 2015 IF: 1,3

13. Guillén-Navarro E; Sánchez-Iglesias S, Domingo-Jimenez R; Victoria B; Ruiz-Riquelme A,Rábano A, Loidi L, Beiras A, González-Méndez B, Ramos A, Lopez González V, Ballesta-Martínez MJ, Garrido- Pumar M, Aguiar P, Ruibal A, Requena JR, Aráujo-Vilar D (corresponding author). A new seipin-associated neurodegenerative syndrome. Journal of Medical Genetics. 50; 401-409, 2013 IF: 6.36 

14, David Araújo Vilar; Berta Victoria Martínez; Blanca González Méndez; Francisco Barreiro Morandeira; Beatriz Fernández Rodríguez; Rubén Cereijo; José Gallego Escuredo; Francesc Villarroya; Alberto Pañeda Menéndez. Histological and molecular features of lipomatous and non lipomatous adipose tissue from subjects with familial partial lipodystrophy due to LMNA mutations. Clinical Endocrinology. 76: 816-824, 2012. IF: 3.398

15. Araujo-Vilar D. Congenital generalized lipodystrophy versus Berardinelli-Seip syndrome. An. Pediatr (Barc.). 2011; 74: 423 - 424 IF:0.35

16. Diego Peteiro-Gonzalez, Beatriz Fernandez-Rodriguez, Jose M Cabezas-Agrícola, David Araujo- Vilar (corresponding author). Severe localized lipoatrophy related to therapy with insulin analogs in type 1a diabetes mellitus. Diabetes Res Clin Pract 2011 Mar;91(3):e61-3. IF: 2.16

17.  Berta Victoria, Marta Cuervo, José Manuel Cabezas-Agrícola, Blanca González-Méndez, Giovanna Lattanzi, Rosalba Del Coco, Lourdes Loidi, Francisco Barreiro, Carlos Calvo, David Araújo-Vilar (corresponding author). Reduced adipogenic gene expression in fibroblasts from a patient with type 2 congenital generalized lipodystrophy Diabetic Medicine 2010, 27: 1178–1187. IF: 2.87

18. Joaquin Lado-Abeal, Rosa-Maria Calvo, Berta Victoria, Isabel Castro, Maria Jesus Obregon, David Araujo-Vilar. Regional decrease of subcutaneous adipose tissue in patients with type 2 familial partial lipodystrophy is associated with changes in thyroid hormone metabolism. Thyroid. 2010 Apr; 20(4):419-24 IF: 4.5

19. Araújo-Vilar D, Giovanna Lattanzi, Blanca González-Méndez, Ana Teresa Costa-Freitas, Daniel Prieto, Marta Columbaro, Elisabetta Mattioli, Berta Victoria, Noelia Martínez-Sánchez, Alia Ramazanova, Máximo Fraga, Andrés Beiras, Jerónimo Forteza, Lourdes Domínguez-Gerpe, Carlos Calvo, Joaquin Lado-Abeal Site-dependent differences in both prelamin A and adipogenic genes in subcutaneous adipose tissue of patients with type 2 familial partial lipodystrophy. J Medical Genetics 2009, 46: 40-8. IF: 6.36 

20.  Domínguez-Gerpe L, Araújo-Vilar D. Prematurely Aged Children: Molecular Alterations Leading to Hutchinson-Gilford Progeria and Werner Syndromes. Current Aging Science 2008; 1:202-212.

21. Araújo-Vilar D, Joaquin Lado-Abeal, Fernando Palos-Paz, Giovanna Lattanzi, Manuel Angel Bandín, Diego Bellido, Lourdes Domínguez-Gerpe, Carlos Calvo, Oscar Pérez, Alia Ramazanova, Noelia Martínez-Sánchez, Berta Victoria, Costa Freitas AT. A new clinical condition associated with a novel mutation in LMNA gene, characterized by partial lipodystrophy, insulin-resistance, aortic stenosis and hypertrophic miocardiopathy. Clinical Endocrinology 2008 Jul;69(1):61-8.

22. Araujo-Vilar D, Loidi L, Dominguez F, Cabezas-Cerrato J. Phenotypic gender differences in subjects with familial partial lipodystrophy (Dunnigan variety) due to a nuclear lamin A/C R482W mutation. Horm Metab Res. 2003 Jan;35(1):29-35.

23. Araújo-Vilar D. Lipodistrofias: bases moleculares y características clínicas. Endocrinología y Nutrición. 2003, 50: 133-44

24. Type 1 familial partial lipodystrophy: understanding the Köbberling syndrome.
Este sitio web utiliza cookies para facilitar y mejorar la navegación. Si continúas navegando, consideramos que aceptas su uso. POLITICA DE COOKIES